PARP9 and diffuse large B-cell lymphoma: As a consequence, PARP9 mediates proliferation, survival, and chemoresistance in DLBCL by repressing the anti-proliferative and pro-apoptotic IFN-STAT1-IRF1-p53 axis (110).